A client in the ICU is prescribed Famotidine. Which statement best describes the reason this drug will help the client?

A. This drug will prevent the client from getting a bacterial infection while in the ICU.: Famotidine does not have antibacterial properties and is not used to prevent infections. Its therapeutic effect is limited to reducing stomach acid secretion. B. This drug will help control the client’s pain and reduce the amount of opioids needed.: Famotidine does not possess analgesic properties. Pain management in ICU clients typically involves opioids or non-opioid analgesics. C. This drug will help the client to breathe easier while on the ventilator.: Famotidine does not act on the respiratory system or improve oxygenation. It is prescribed to reduce the risk of gastric irritation or aspiration, but it does not affect ventilatory mechanics or gas exchange. D. This drug will decrease gastric acid production and reduce the chance for stress ulcers.: Famotidine is an H2 receptor antagonist that suppresses gastric acid secretion. In critically ill clients, it helps prevent stress-related mucosal damage and gastrointestinal bleeding caused by physiological stress and mechanical ventilation.